Nimmerjahn F - Search Results

1

IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy.

Kallolimath S, Sun L, Palt R, Föderl-Höbenreich E, Hermle A, Voss L, Kleim M, Nimmerjahn F, Gach JS, Hitchcock L, Chen Q, Melnik S, Eminger F, Lux A, Steinkellner H. Kallolimath S, et al. Among authors: nimmerjahn f. Front Immunol. 2024 Oct 24;15:1490515. doi: 10.3389/fimmu.2024.1490515. eCollection 2024. Front Immunol. 2024. PMID: 39512357 Free PMC article.

2

Of mice and men: the need for humanized mouse models to study human IgG activity in vivo.

Lux A, Nimmerjahn F. Lux A, et al. Among authors: nimmerjahn f. J Clin Immunol. 2013 Jan;33 Suppl 1:S4-8. doi: 10.1007/s10875-012-9782-0. Epub 2012 Sep 5. J Clin Immunol. 2013. PMID: 22948744 Review.

3

Impact of immune complex size and glycosylation on IgG binding to human FcγRs.

Lux A, Yu X, Scanlan CN, Nimmerjahn F. Lux A, et al. Among authors: nimmerjahn f. J Immunol. 2013 Apr 15;190(8):4315-23. doi: 10.4049/jimmunol.1200501. Epub 2013 Mar 18. J Immunol. 2013. PMID: 23509345

4

How immunoglobulin G antibodies kill target cells: revisiting an old paradigm.

Biburger M, Lux A, Nimmerjahn F. Biburger M, et al. Among authors: nimmerjahn f. Adv Immunol. 2014;124:67-94. doi: 10.1016/B978-0-12-800147-9.00003-0. Adv Immunol. 2014. PMID: 25175773 Review.

5

No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer.

Lux A, Nimmerjahn F. Lux A, et al. Among authors: nimmerjahn f. Cancer Cell. 2015 Jan 12;27(1):10-1. doi: 10.1016/j.ccell.2014.12.010. Cancer Cell. 2015. PMID: 25584890 Free article.

6

FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities.

Nimmerjahn F, Gordan S, Lux A. Nimmerjahn F, et al. Trends Immunol. 2015 Jun;36(6):325-36. doi: 10.1016/j.it.2015.04.005. Epub 2015 May 13. Trends Immunol. 2015. PMID: 25981969 Review.

7

Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized Mice.

Schwab I, Lux A, Nimmerjahn F. Schwab I, et al. Among authors: nimmerjahn f. Cell Rep. 2015 Oct 20;13(3):610-620. doi: 10.1016/j.celrep.2015.09.013. Epub 2015 Oct 8. Cell Rep. 2015. PMID: 26456831 Free article.

8

IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice.

Kao D, Lux A, Schaffert A, Lang R, Altmann F, Nimmerjahn F. Kao D, et al. Among authors: nimmerjahn f. Eur J Immunol. 2017 Dec;47(12):2070-2079. doi: 10.1002/eji.201747208. Epub 2017 Aug 29. Eur J Immunol. 2017. PMID: 28771702 Free article.

9

Impact of Plasma Membrane Domains on IgG Fc Receptor Function.

Kara S, Amon L, Lühr JJ, Nimmerjahn F, Dudziak D, Lux A. Kara S, et al. Among authors: nimmerjahn f. Front Immunol. 2020 Jun 30;11:1320. doi: 10.3389/fimmu.2020.01320. eCollection 2020. Front Immunol. 2020. PMID: 32714325 Free PMC article. Review.

10

Expression Profiling and Glycan Engineering of IgG Subclass 1-4 in Nicotiana benthamiana.

Kallolimath S, Hackl T, Gahn R, Grünwald-Gruber C, Zich W, Kogelmann B, Lux A, Nimmerjahn F, Steinkellner H. Kallolimath S, et al. Among authors: nimmerjahn f. Front Bioeng Biotechnol. 2020 Jul 24;8:825. doi: 10.3389/fbioe.2020.00825. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32793574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters